Resultados da busca - Lee Honigberg
- Mostrando 1 - 20 resultados de 21
- Ir para a próxima página
-
1
-
2
-
3
Pharmacokinetics and pharmacodynamic effect of crenezumab on plasma and cerebrospinal fluid beta-amyloid in patients with mild-to-moderate Alzheimer’s disease por Kenta Yoshida, Anita Moein, Tobias Bittner, Susanne Ostrowitzki, Helen Lin, Lee Honigberg, Jin Y. Jin, Angelica Quartino
Publicado em 2020Artigo -
4
Identification of longitudinally dynamic biomarkers in Alzheimer’s disease cerebrospinal fluid by targeted proteomics por Kristin R. Wildsmith, Stephen Schauer, Ashley M. Smith, David Arnott, Yuda Zhu, Joshua Haznedar, Surinder Kaur, W. Rodney Mathews, Lee Honigberg
Publicado em 2014Artigo -
5
The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy por Lee Honigberg, Ashley M. Smith, Mint Sirisawad, Erik Verner, David Loury, Betty Chang, Shyr Li, Zhengying Pan, Douglas H. Thamm, Richard A. Miller, Joseph J. Buggy
Publicado em 2010Artigo -
6
Identification of Substrates of Human Protein-tyrosine Phosphatase PTPN22 por Jian Wu, Anjali Katrekar, Lee Honigberg, Ashley M. Smith, Marion Conn, Jie Tang, D. Molkentin Jeffery, Kyle Mortara, Jun Sampang, Steven Williams, Joseph J. Buggy, James M. Clark
Publicado em 2006Artigo -
7
Proteomics approach identifies aqueous humor biomarkers in retinal diseases por Kevin Huang, CJ Schofield, Trung Nguy, Randall C. Dere, Vincent Wolowski, Juliane Siebourg‐Polster, Andreas Dieckmann, Justus G. Garweg, Michael Chang, Lee Honigberg, Jason A. Hackney, Vahan B. Indjeian
Publicado em 2025Artigo -
8
Functional Studies on the IBD Susceptibility Gene IL23R Implicate Reduced Receptor Function in the Protective Genetic Variant R381Q por Svetlana Pidasheva, Sara Trifari, Anne Phillips, Jason A. Hackney, Yan Ma, Ashley Smith, Sue J. Sohn, Hergen Spits, Randall D. Little, Timothy W. Behrens, Lee Honigberg, Nico Ghilardi, Hilary Clark
Publicado em 2011Artigo -
9
Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF por Daniel S. Spellman, Kristin R. Wildsmith, Lee Honigberg, Marianne Tuefferd, David Baker, Nandini Raghavan, Angus C. Nairn, Pascal Croteau, Michael Schirm, René Allard, Julie Lamontagne, Daniel Chelsky, Steven C. Hoffmann, William Z. Potter
Publicado em 2015Artigo -
10
Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration por Frank G. Holz, Srinivas R. Sadda, Brandon Busbee, Emily Y. Chew, Paul Mitchell, Adnan Tufail, Christopher Brittain, Daniela Ferrara, Sarah Gray, Lee Honigberg, Jillian Martin, Barbara Tong, Jason S. Ehrlich, Neil M. Bressler
Publicado em 2018Artigo -
11
Deep Learning to Predict Geographic Atrophy Area and Growth Rate from Multimodal Imaging por Neha Anegondi, Simon S. Gao, Verena Steffen, Richard F. Spaide, Srinivas R. Sadda, Frank G. Holz, Christina Rabe, Lee Honigberg, Elizabeth M. Newton, Julia Cluceru, Michael Kawczynski, Thomas Bengtsson, Daniela Ferrara, Qi Yang
Publicado em 2022Artigo -
12
Macular Sensitivity Endpoints in Geographic Atrophy: Exploratory Analysis of Chroma and Spectri Clinical Trials por Dolly S. Chang, Natalia F. Callaway, Verena Steffen, Karl G. Csaky, Robyn H. Guymer, David G. Birch, Praveen J. Patel, Michael S. Ip, Simon S. Gao, Jayla Briggs, Lee Honigberg, Phillip Lai, Daniela Ferrara, Yasir J. Sepah
Publicado em 2023Artigo -
13
Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration por Brian L. Yaspan, David F. Williams, Frank G. Holz, Carl D. Regillo, Zhengrong Li, Amy Dressen, Menno van Lookeren Campagne, Kha Le, Robert Graham, Tatiana Beres, Tushar Bhangale, Lee Honigberg, Ashley Smith, Erin C. Henry, Carole Ho, Erich C. Strauss
Publicado em 2017Artigo -
14
ABBY por Jeffrey L. Cummings, Sharon Cohen, Christopher H. van Dyck, Mark Brody, Craig Curtis, Yong‐Yeon Cho, Michael E. Ward, Michel Friesenhahn, Christina Rabe, Flávia Brunstein, Angelica Quartino, Lee Honigberg, Reina N. Fuji, David Clayton, Deborah L. Mortensen, Carole Ho, Robert Paul
Publicado em 2018Artigo -
15
Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mil... por Stephen Salloway, Lee Honigberg, Yong‐Yeon Cho, Michael E. Ward, Michel Friesenhahn, Flávia Brunstein, Angelica Quartino, David Clayton, Deborah L. Mortensen, Tobias Bittner, Carole Ho, Christina Rabe, Stephen Schauer, Kristin R. Wildsmith, Reina N. Fuji, Shehnaaz Suliman, Eric M. Reiman, Kewei Chen, Robert Paul
Publicado em 2018Artigo -
16
Development of a therapeutic anti-HtrA1 antibody and the identification of DKK3 as a pharmacodynamic biomarker in geographic atrophy por Irene Tom, Victoria C. Pham, Kenneth J. Katschke, Wěi Li, Wei‐Ching Liang, Johnny Gutierrez, Andrew Ah Young, Isabel Figueroa, Shadi Toghi Eshghi, Chingwei V. Lee, Jitendra Kanodia, Scott J. Snipas, Guy S. Salvesen, Phillip Lai, Lee Honigberg, Menno van Lookeren Campagne, Daniel Kirchhofer, Amos Baruch, Jennie R. Lill
Publicado em 2020Artigo -
17
The Alzheimer's Prevention Initiative Autosomal‐Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical <i>PSEN1</i> E280A mutation carriers to eval... por Pierre N. Tariot, Francisco Lopera, Jessica B. Langbaum, Ronald G. Thomas, Suzanne Hendrix, Lon S. Schneider, Silvia Ríos‐Romenets, Margarita Giraldo, Natalia Acosta‐Baena, Carlos Tobón, Cláudia Ramos, Alejandro Palacios Espinosa, Yong‐Yeon Cho, Michael E. Ward, David Clayton, Michael Friesenhahn, Howard Mackey, Lee Honigberg, Sandra Sanabria Bohórquez, Kewei Chen, Trisha Walsh, Carolyn Langlois, Eric M. Reiman
Publicado em 2018Artigo -
18
A Phase 1 study of <scp>GDC</scp>‐0134, a dual leucine zipper kinase inhibitor, in <scp>ALS</scp> por Jonathan Katz, Jeffrey D. Rothstein, Merit Cudkowicz, Angela Genge, Björn Oskarsson, Avis B. Hains, Chen Chen, Joshua Galanter, Braydon L. Burgess, Yong‐Yeon Cho, Geoffrey A. Kerchner, Felix L. Yeh, Arundhati Sengupta Ghosh, Sravanthi Cheeti, Logan Brooks, Lee Honigberg, Jessica A. Couch, Michael E. Rothenberg, Flávia Brunstein, Khema R. Sharma, Leonard van den Berg, James Berry, Jonathan D. Glass
Publicado em 2022Artigo -
19
Systems genomics in age-related macular degeneration por Anneke I. den Hollander, Robert F. Mullins, Luz D. Orozco, Andrew P. Voigt, Hsu-Hsin Chen, Tobias Strunz, Felix Graßmann, Jonathan L. Haines, Jonas J. W. Kuiper, Santa J. Tumminia, Rando Allikmets, Gregory S. Hageman, Dwight Stambolian, Caroline C. W. Klaver, Jef D. Boeke, Hao Chen, Lee Honigberg, Suresh Katti, Kelly A. Frazer, Bernhard H. F. Weber, Michael B. Gorin
Publicado em 2022Artigo -
20
Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease por Susanne Ostrowitzki, Tobias Bittner, Kaycee M. Sink, Howard Mackey, Christina Rabe, Lawrence S. Honig, Emanuele Cassetta, Mark Woodward, Merçé Boada, Christopher H. van Dyck, Timo Grimmer, Dennis J. Selkoe, Andres Schneider, Kathleen Blondeau, Nan Hu, Angelica Quartino, David Clayton, Michael Dolton, Yifan Dang, Beth L. Ostaszewski, Sandra Sanabria Bohórquez, Michael Rabbia, Balázs István Tóth, Udo Eichenlaub, Jillian Smith, Lee Honigberg, Rachelle S. Doody
Publicado em 2022Artigo
Ferramentas de busca:
Assuntos relacionados
Medicine
Internal medicine
Biology
Disease
Biochemistry
Clinical trial
Immunology
Pathology
Gene
Ophthalmology
Alzheimer's disease
Antibody
Macular degeneration
Pharmacology
Alternative medicine
Genetics
Geographic atrophy
Placebo
Atrophy
Biomarker
Cerebrospinal fluid
Chemistry
Computational biology
Computer science
Dementia
Genotype
Oncology
Psychology
Single-nucleotide polymorphism
Adverse effect